Accession Number: | 0001192482-20-000128 |
Date: | 2020-02-03 |
Issuer: | RECRO PHARMA, INC. (REPH) |
Original Submission Date: |
LAKE RYAN DAVID
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-03 | A | 12,000 | a | $0.00 | 58,738 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 16.62 | 2020-02-03 | deemed execution date | A | 45,000 (a) | 2030-02-03 | common stock 45,000 | $16.62 | 45,000 | direct |
ID | footnote |
---|---|
f1 | all of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning february 3, 2021, subject to continued service to the company. vested shares will be delivered to the reporting person within 30 days following each respective vesting date. |
f2 | the stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued service to the company. |